Observational Study of Survival Outcomes of Stage IV Cancer Patients

• Conditions: Stage IV Cancer (Solid Tumors Only); Survival

• Registration Number: NCT01843985
• Lead Sponsor: Cure Cancer Worldwide Corporation

Brief Summary

Patients diagnosed with Stage IV cancer (solid tumors only) are evaluated to determine whether they are candidates for traditional chemotherapy. If eligible, patients are offered traditional chemotherapy, low-dose chemotherapy, or palliative care. If ineligible, patients are offered low-dose chemotherapy or palliative care. Patients will be monitored for 5 years and survival data recorded.

Detailed Description

Not available

Study Timeline

• Status Verified: 2013-04
• Study First Submitted: 2013-04-27
• Study First Submitted QC: 2013-04-27
• Last Update Submitted: 2013-04-27
• Study First Posted: 2013-05-01
• Last Update Posted: 2013-05-01
• Study Start: 2013-06
• Primary Completion: 2018-12
• Study Completion: 2018-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

• Presenting with Stage IV cancer (solid tumors only)

Exclusion Criteria

• Patient declines inclusion

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
survival	months 1, 2, 3, 4, 6, 9, 12, 18, 24, 36, 48, 60

Trial Locations

Locations (1)

Yang Ling Demonstration Zone Hospital; 🇨🇳 Yang Ling, Shaanxi, China

Yang Ling Demonstration Zone Hospital

🇨🇳Yang Ling, Shaanxi, China